PATENT CLAIM ANALYSIS

Application Number: 15748827
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-05
Patent Classification: ["514", "408000"]

Abstract:
The invention relates to new compounds with low cytotoxicity for blocking ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of treating disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders and autoimmune disorders and metabolic disorders.

Claim (Index 16):
A method for treating a neoplastic disease, comprising administrating an effective amount of the compound of any of  claim 1  to a cell or to a subject in need thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.36111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15746964', '14417477', '14524204', '14654296', '12920050']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6997673929875498
- 35 USC 102 Novelty (BERT): 0.5110396188293593
- Combined Prediction Score: 0.6808946155717308
- Mean Citation Score: 250.257446
- Max Citation Score: 272.47165
- Similarity Product: 206.2629308822065

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test